CD8A and neoplasm: CD4 +T cells characterized by class II‐restricted and tumor‐specific has been validated to innately infiltrate in TME and exert anticancer duty with the assistance of CD8+ T cells or, with the secretion of type 1 cytokines, or with the direct killing of tumor cells CD4+ T cells.50